Clinical trial

Study of Neoadjuvant Docetaxel and Cyclophosphamide in Locally Advanced or Node Positive Primary Breast Cancer With Companion Pharmacokinetic and Pharmacogenomic Analyses

NCT01540110

Study summary

ClinicalTrials.gov

Study of Neoadjuvant Docetaxel and Cyclophosphamide in Locally Advanced or Node Positive Primary Breast Cancer With Companion Pharmacokinetic and Pharmacogenomic Analyses

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Neoadjuvant Docetaxel and Cyclophosphamide Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-08-11

PhasePHASE2

Conditions

Breast Cancerverified · MONDO: breast cancer

Interventions

Neoadjuvant Docetaxel and CyclophosphamideDRUG

Sponsors & collaborators

National Cancer Centre, Singaporelead sponsor

Mapped research locations

SingaporeSingapore1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01540110 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.